Greggs Plc (LON:GRG) reports strong trading results for early 2025, with sales rising 7.4% and ongoing expansion plans, as year-end expectations remain stable...
LondonMetric Property Plc (LON:LMP) reports impressive full-year results for FY 2025, showcasing record net rental income and earnings, driven by strategic growth in logistics...
AstraZeneca has successfully acquired EsoBiotec, enhancing its cancer therapy capabilities with innovative in vivo cell therapies that promise faster treatment access...
With a significant £8 million contract extension in Europe and a landmark $11 million deal with a national telco in Armenia, Cerillion is doubling down on high-value markets...
Poolbeg Pharma plc (LON:POLB) announces a conditional fundraising aimed at raising £4.1 million to drive innovative pharmaceutical developments and address unmet medical needs...
Cizzle Biotechnology Holdings Plc has raised £150,000 to advance its CIZ1B early cancer test, enhancing access to innovative diagnostics in the UK and Europe...
Hercules Site Services Plc has officially rebranded to Hercules Plc, effective May 2025, signaling a new era for the UK infrastructure and construction sectors...
Poolbeg Pharma Plc has released its audited results for 2024, highlighting significant advancements in cancer immunotherapy, including the promising POLB 001 therapy...
Greggs Plc (LON:GRG) reports strong trading results for early 2025, with sales rising 7.4% and ongoing expansion plans, as year-end expectations remain stable...
LondonMetric Property Plc (LON:LMP) reports impressive full-year results for FY 2025, showcasing record net rental income and earnings, driven by strategic growth in logistics...
AstraZeneca has successfully acquired EsoBiotec, enhancing its cancer therapy capabilities with innovative in vivo cell therapies that promise faster treatment access...
With a significant £8 million contract extension in Europe and a landmark $11 million deal with a national telco in Armenia, Cerillion is doubling down on high-value markets...
Poolbeg Pharma plc (LON:POLB) announces a conditional fundraising aimed at raising £4.1 million to drive innovative pharmaceutical developments and address unmet medical needs...
Cizzle Biotechnology Holdings Plc has raised £150,000 to advance its CIZ1B early cancer test, enhancing access to innovative diagnostics in the UK and Europe...
Hercules Site Services Plc has officially rebranded to Hercules Plc, effective May 2025, signaling a new era for the UK infrastructure and construction sectors...
Poolbeg Pharma Plc has released its audited results for 2024, highlighting significant advancements in cancer immunotherapy, including the promising POLB 001 therapy...
